These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2888875)

  • 1. In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor.
    Eva C; Costa E
    J Pharmacol Exp Ther; 1987 Sep; 242(3):888-94. PubMed ID: 2888875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations.
    Ehlert FJ; Rathbun BE
    Mol Pharmacol; 1990 Jul; 38(1):148-58. PubMed ID: 2370853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
    Onali P; Olianas MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
    Brown JH; Goldstein D
    Mol Pharmacol; 1986 Dec; 30(6):566-70. PubMed ID: 3023810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.
    Waelbroeck M; Robberecht P; Chatelain P; Christophe J
    J Cyclic Nucleotide Res; 1981; 7(3):173-85. PubMed ID: 7287969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes.
    Smith MM; Harden TK
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):197-210. PubMed ID: 3998232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism.
    Brown JH; Brown SL
    J Biol Chem; 1984 Mar; 259(6):3777-81. PubMed ID: 6323440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
    Olianas MC; Onali P; Neff NH; Costa E
    Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes.
    Odagaki Y; Fuxe K
    J Pharmacol Exp Ther; 1995 Jul; 274(1):337-44. PubMed ID: 7616417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of muscarinic receptors to adenylate cyclase in the rabbit myocardium: effects of receptor inactivation.
    Ehlert FJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):23-30. PubMed ID: 3806386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
    Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium.
    Pontzer NJ; Crews FT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):921-9. PubMed ID: 2162952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.